Historical Stock Price
SNDX historical stock prices picture
Syndax Pharmaceuticals (SNDX) has the following price history information. Looking back at SNDX historical stock prices for the last five trading days, on April 22, 2024, SNDX opened at $20.99, traded as high as $21.37 and as low as $20.75, and closed at $20.96. Trading volume was a total of 665.00K shares. On April 23, 2024, SNDX opened at $21.07, traded as high as $21.54 and as low as $20.91, and closed at $20.97. Trading volume was a total of 872.10K shares. On April 24, 2024, SNDX opened at $21.02, traded as high as $21.17 and as low as $20.64, and closed at $20.79. Trading volume was a total of 367.60K shares. On April 25, 2024, SNDX opened at $20.43, traded as high as $20.80 and as low as $20.13, and closed at $20.57. Trading volume was a total of 589.00K shares. On April 26, 2024, SNDX opened at $20.59, traded as high as $21.23 and as low as $20.48, and closed at $21.06. Trading volume was a total of 679.00K shares.

SNDX Historical Stock Prices By Date:

SNDX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Syndax Pharmaceuticals shares, starting with a $10,000 purchase of SNDX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/03/2016
End date: 04/26/2024
Start price/share: $12.01
End price/share: $21.06
Dividends collected/share: $0.00
Total return: 75.35%
Average Annual Total Return: 7.13%
Starting investment: $10,000.00
Ending investment: $17,530.57
Years: 8.15
Date Open High Low Close Volume
04/22/2024 $20.99 $21.37 $20.75 $20.96 665.00K
04/23/2024 $21.07 $21.54 $20.91 $20.97 872.10K
04/24/2024 $21.02 $21.17 $20.64 $20.79 367.60K
04/25/2024 $20.43 $20.80 $20.13 $20.57 589.00K
04/26/2024 $20.59 $21.23 $20.48 $21.06 679.00K
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of cancer therapies. Co.'s two primary product candidates are, revumenib (SNDX-5613), and axatilimab (SNDX-6352). Co. is developing SNDX-5613, a small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia, and acute myeloid leukemia, or AML, and NPM1 mutant AML. Co. is also developing SNDX-6352, a monoclonal antibody that blocks the colony stimulating factor 1, in chronic graft-versus-host disease, as well as idiopathic pulmonary fibrosis.
Date Close
04/22/2024$20.96
04/23/2024$20.97
04/24/2024$20.79
04/25/2024$20.57
04/26/2024$21.06
SNDX is categorized under the Healthcare sector; below are some other companies in the same sector:

SNGX Historical Stock Prices
SNNA Historical Stock Prices
SNOA Historical Stock Prices
SNPX Historical Stock Prices
SNSE Historical Stock Prices
SNSS Historical Stock Prices
SNTA Historical Stock Prices
SNTS Historical Stock Prices
SOLY Historical Stock Prices
SONN Historical Stock Prices

Also explore: SNDX shares outstanding history

Email EnvelopeFree SNDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


SNDX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.